Results 161 to 170 of about 26,852 (242)
Physician Billing for Advance Care Planning Among Medicare Fee-For-Service Beneficiaries, 2016–2021
Nan Wang +4 more
openaire +2 more sources
Annual Reports to the ESA Council ESA 110th Annual Meeting July, 2025
The Bulletin of the Ecological Society of America, EarlyView.
wiley +1 more source
AI Hallucinations in Tourism: How Errors Impact Consumer Trust and Recommendation Acceptance
ABSTRACT Generative artificial intelligence (GenAI) is quickly transforming travel planning; however, its outputs can include hallucinations, which are plausible yet false statements that can undermine user judgement. Eliminating hallucinations in GenAI technology is currently impossible.
Francisco Rejón‐Guardia +2 more
wiley +1 more source
Unfairness toward rural beneficiaries in Medicare's hierarchical conditions categories score. [PDF]
Parikh RB +8 more
europepmc +1 more source
ABSTRACT This study examines how money attitudes moderate the relationship between personality traits and early pension withdrawal behaviour in the context of South Africa's new Two‐Pot retirement system. Drawing on structural equation modelling with data from over 5000 retirement fund members, whether Money Prudence and Money Anxiety condition the ...
Paul Prinn Nixon, Evan Gilbert
wiley +1 more source
Medicare at a crossroads: A conversation with Dr. Mark McClellan on program reforms and the growth of Medicare Advantage. [PDF]
McClellan M, Ippolito B.
europepmc +1 more source
ABSTRACT A growing body of research shows that training in LGBTQ+ affirming counseling (LGBTQ+ AC) positively impacts counselors’ perceived knowledge and skills in providing mental health services to LGBTQ+ communities. Existing program evaluations of LGBTQ+ AC, however, have primarily used synchronous delivery formats and cultural competency models ...
Amber L. Pope +7 more
wiley +1 more source
Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population. [PDF]
Meyer KB +10 more
europepmc +1 more source
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono +10 more
wiley +1 more source

